CD1D and colorectal carcinoma: One of the genes that drew our interest was CD1D, an MHC-like molecule involved in antigen presentation of lipids and glycoproteins, which was recently shown to enhance cytotoxic activity of invariant-NKT cells against CRC cell lines [25].